169 related articles for article (PubMed ID: 37354999)
1. Glycosylation shapes the efficacy and safety of diverse protein, gene and cell therapies.
Rocamora F; Peralta AG; Shin S; Sorrentino J; Wu MYM; Toth EA; Fuerst TR; Lewis NE
Biotechnol Adv; 2023 Oct; 67():108206. PubMed ID: 37354999
[TBL] [Abstract][Full Text] [Related]
2. Glycoengineered antibodies: towards the next-generation of immunotherapeutics.
Mastrangeli R; Palinsky W; Bierau H
Glycobiology; 2019 Mar; 29(3):199-210. PubMed ID: 30289453
[TBL] [Abstract][Full Text] [Related]
3. Modulating carbohydrate-protein interactions through glycoengineering of monoclonal antibodies to impact cancer physiology.
Chiang AW; Li S; Spahn PN; Richelle A; Kuo CC; Samoudi M; Lewis NE
Curr Opin Struct Biol; 2016 Oct; 40():104-111. PubMed ID: 27639240
[TBL] [Abstract][Full Text] [Related]
4. A versatile design platform for glycoengineering therapeutic antibodies.
Ludwig SD; Bernstein ZJ; Agatemor C; Dammen-Brower K; Ruffolo J; Rosas JM; Post JD; Cole RN; Yarema KJ; Spangler JB
MAbs; 2022; 14(1):2095704. PubMed ID: 35815437
[TBL] [Abstract][Full Text] [Related]
5. Influence of N-glycosylation on effector functions and thermal stability of glycoengineered IgG1 monoclonal antibody with homogeneous glycoforms.
Wada R; Matsui M; Kawasaki N
MAbs; 2019; 11(2):350-372. PubMed ID: 30466347
[TBL] [Abstract][Full Text] [Related]
6. N-Glycosylation Design and Control of Therapeutic Monoclonal Antibodies.
Sha S; Agarabi C; Brorson K; Lee DY; Yoon S
Trends Biotechnol; 2016 Oct; 34(10):835-846. PubMed ID: 27016033
[TBL] [Abstract][Full Text] [Related]
7. Generation of site-distinct N-glycan variants for in vitro bioactivity testing.
Brühlmann D; Vuillemin T; Satwekar A; Galano E; Palmese A; D'Angelo A; Manco Z; Souquet J; Broly H; Sauer M; Hemberger J; Jordan M
Biotechnol Bioeng; 2019 May; 116(5):1017-1028. PubMed ID: 30659587
[TBL] [Abstract][Full Text] [Related]
8. The Formidable Challenge of Controlling High Mannose-Type N-Glycans in Therapeutic mAbs.
Mastrangeli R; Audino MC; Palinsky W; Broly H; Bierau H
Trends Biotechnol; 2020 Oct; 38(10):1154-1168. PubMed ID: 32616303
[TBL] [Abstract][Full Text] [Related]
9. Glycosylation of monoclonal antibody products: Current status and future prospects.
Batra J; Rathore AS
Biotechnol Prog; 2016 Sep; 32(5):1091-1102. PubMed ID: 27677099
[TBL] [Abstract][Full Text] [Related]
10. High-throughput N-glycan screening method for therapeutic antibodies using a microchip-based DNA analyzer: a promising methodology for monitoring monoclonal antibody N-glycosylation.
Kinoshita M; Nakajima K; Yamamoto S; Suzuki S
Anal Bioanal Chem; 2021 Aug; 413(19):4727-4738. PubMed ID: 34080034
[TBL] [Abstract][Full Text] [Related]
11. Antibody glycosylation and its impact on the pharmacokinetics and pharmacodynamics of monoclonal antibodies and Fc-fusion proteins.
Liu L
J Pharm Sci; 2015 Jun; 104(6):1866-1884. PubMed ID: 25872915
[TBL] [Abstract][Full Text] [Related]
12. Cell Free Remodeling of Glycosylation of Antibodies.
Mota LM; Tayi VS; Butler M
Methods Mol Biol; 2022; 2370():117-146. PubMed ID: 34611867
[TBL] [Abstract][Full Text] [Related]
13. Plant glycoengineering for designing next-generation vaccines and therapeutic proteins.
Strasser R
Biotechnol Adv; 2023 Oct; 67():108197. PubMed ID: 37315875
[TBL] [Abstract][Full Text] [Related]
14. Sculpting therapeutic monoclonal antibody N-glycans using endoglycosidases.
Trastoy B; Du JJ; García-Alija M; Li C; Klontz EH; Wang LX; Sundberg EJ; Guerin ME
Curr Opin Struct Biol; 2022 Feb; 72():248-259. PubMed ID: 34998123
[TBL] [Abstract][Full Text] [Related]
15. With or without sugar? (A)glycosylation of therapeutic antibodies.
Hristodorov D; Fischer R; Linden L
Mol Biotechnol; 2013 Jul; 54(3):1056-68. PubMed ID: 23097175
[TBL] [Abstract][Full Text] [Related]
16.
Majewska NI; Tejada ML; Betenbaugh MJ; Agarwal N
Annu Rev Chem Biomol Eng; 2020 Jun; 11():311-338. PubMed ID: 32176521
[TBL] [Abstract][Full Text] [Related]
17. Improving Immunotherapy Through Glycodesign.
Buettner MJ; Shah SR; Saeui CT; Ariss R; Yarema KJ
Front Immunol; 2018; 9():2485. PubMed ID: 30450094
[TBL] [Abstract][Full Text] [Related]
18. Impact of N-Linked Glycosylation on Therapeutic Proteins.
Chen B; Liu W; Li Y; Ma B; Shang S; Tan Z
Molecules; 2022 Dec; 27(24):. PubMed ID: 36557993
[TBL] [Abstract][Full Text] [Related]
19. Recent Advances in Biologic Therapeutic N-Glycan Preparation Techniques and Analytical Methods for Facilitating Biomanufacturing Automation.
Tiwold EK; Gyorgypal A; Chundawat SPS
J Pharm Sci; 2023 Jun; 112(6):1485-1491. PubMed ID: 36682489
[TBL] [Abstract][Full Text] [Related]
20. Glycosylation engineering of therapeutic IgG antibodies: challenges for the safety, functionality and efficacy.
Mimura Y; Katoh T; Saldova R; O'Flaherty R; Izumi T; Mimura-Kimura Y; Utsunomiya T; Mizukami Y; Yamamoto K; Matsumoto T; Rudd PM
Protein Cell; 2018 Jan; 9(1):47-62. PubMed ID: 28597152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
